Case Type: Mergers & Acquisitions

Freeline Therapeutics Holdings plc (Nasdaq: FRLN), relating to its proposed sale to Sycona Ltd. Under the terms of the agreement, FRLN shareholders will receive $6.50 in cash per share they own.

P&F Industries, Inc. (Nasdaq: PFIN), relating to its proposed sale to ShoreView Industries. Under the terms of the agreement, PFIN shareholders are expected to receive $13.00 in cash per share they own.

Homology Medicines, Inc. (Nasdaq: FIXX), relating to its proposed merger with Q32 Bio, Inc. Under the terms of the agreement, FIXX shareholders are expected to own approximately 25% of the combined company.

GAN Limited (Nasdaq: GAN), relating to its proposed sale to Sega Sammy Creation Inc. Under the terms of the agreement, GAN shareholders will receive $1.97 in cash per share they own.

Northern Genesis Acquisition Corp. II (NYSE: NGAB), relating to its 2021 merger with Embark Technology, Inc.

BigBear.ai Holdings, Inc. (NYSE: BBAI), relating to its proposed merger with Pangiam Intermediate Holdings, LLC.

Patriot Transportation Holding, Inc. (Nasdaq: PATI), relating to its proposed sale to United Petroleum Transports, Inc. Under the terms of the agreement, PATI shareholders will receive $16.26 in cash per share they own.

Eargo, Inc. (Nasdaq: EAR), relating to its proposed sale to an affiliate of Patient Square Capital. Under the terms of the agreement, EAR shareholders will receive $2.55 in cash per share they own.

Physicians Realty Trust (NYSE: DOC), relating to its proposed sale to Healthpeak Properties, Inc. Under the terms of the agreement, DOC shareholders will receive 0.674 shares of Healthpeak per share they own.

Miromatrix Medical Inc. (Nasdaq: MIRO), relating to its proposed sale to United Therapeutics Corp. Under the terms of the agreement, MIRO shareholders will receive $3.25 and potentially an additional payment of $1.75 in cash per share they own.